We are live on ! Find out more
ACHV icon

Achieve Life Sciences
ACHV

15 hedge funds and large institutions have $797K invested in Achieve Life Sciences in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.01% more ownership

Funds ownership: 0.01% → 0.02% (+0.01%)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

40% less funds holding

Funds holding: 25 → 15 (-10)

45% less capital invested

Capital invested by funds: $1.46M → $797K (-$659K)

75% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 12

Holders
15
Holders Change
-10
Holders Change %
-40%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
3
Closed
12
Calls
$16K
Puts
–
Net Calls
+$16K
Net Calls Change
+$8K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$163K
2
VF
Virtu Financial
New York
+$59.6K
3
TSS
Two Sigma Securities
New York
+$51.7K
4
Renaissance Technologies
Renaissance Technologies
New York
+$24.4K
5
Citadel Advisors
Citadel Advisors
Florida
+$19.4K

Top Sellers

Rank Fund Capital Flow
1
PAM
Panagora Asset Management
Massachusetts
-$71.1K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$28K
3
Northern Trust
Northern Trust
Illinois
-$25K
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$22K
5
California Public Employees Retirement System
California Public Employees Retirement System
California
-$18K
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
– -$718 -1 Closed
1
2

ACHV Hedge Fund Activity: Q3 2017 in Review

15 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q3 2017, worth a combined $797K — down 45% from $1.46M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of ACHV and 3 opened new positions — a net loss of 9 holders — while 3 trimmed existing stakes and 3 added.

The largest buyer was Vanguard Group, adding an estimated $163K. The largest seller was Panagora Asset Management, cutting an estimated $71.1K.

  • 15 institutional investors held Achieve Life Sciences (ACHV) as of Q3 2017, down from 25 in Q2 2017.
  • Funds reported $797K of Achieve Life Sciences stock for Q3 2017, down 45% quarter-over-quarter.
  • 3 funds opened new Achieve Life Sciences positions in Q3 2017 and 12 closed out, a net change of -9 holders.
  • The largest Achieve Life Sciences buyer in Q3 2017 was Vanguard Group, an estimated $163K added.
  • The largest Achieve Life Sciences seller in Q3 2017 was Panagora Asset Management, an estimated $71.1K sold.

Based on aggregated 13F filings for Q3 2017.